Abstract
Denaturing high-performance liquid chromatography (DHPLC) is a chromatographic mutation analysis technique that is based on temperature-dependent separation of DNA containing mismatched base pairs from polymerase chain reaction (PCR)-amplified DNA fragments. The WAVE system, developed for DHPLC analysis, allows for unattended analysis of 96 samples directly from a PCR plate under a number of different conditions. It utilizes a Peltier cooling platform to maintain sample integrity. Sample detection is achieved via UV absorbance at 260 nm, thereby avoiding the cost, safety, variability, or waste disposal issues associated with radioisotopic, enzyme-linked, or fluorescence detection systems. There are four key aspects to successfully detecting mutations on the WAVE: (1) PCR primer design, (2) PCR protocol, (3) separation gradient, and (4) separation temperature. Provided these procedures are carried out correctly, almost 100% detection of single-nucleotide polymorphisms (SNPs) and small deletion/insertion mutations can be achieved. For this reason, DHPLC is a powerful tool for identifying mutations in candidate genes for hypertension. Key Words: DHPLC; WAVE; hypertension; mutation detection; ALAP gene; HUT2 gene; chromatography; heteroduplex analysis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Taylor, P., Munson, K., and Gjerde, D. Transgenomic, Inc., San Jose, CA. (1999) Detection of Mutations and Polymorphisms on the WAVE™ DNA Fragment Analysis System.
Solari, V., Ennis, S., Yoneda, L., et al. (2003) Mutation analysis of the RET gene in total intestinal ananglionosis by WAVEDNA fragment analysis system.J.Paed.Surg. 38, 497–501.
Eng, C., Brody, L. C., Wagner, T. M., et al. (2001) Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J. Med. Genet. 38, 824–833.
Oefner, P. J. and Underhill, P. A. (1999) DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC). In Current Protocols in Human Genetics (Dracopoli, N. C. and Haines, J., eds.), Wiley-Interscience, New York, pp. 7.10.1–7.10.12.
Choy, Y. S., Dabora, S. L., Hall, F., et al. (1999) Superiority of denaturing highperformance liquid chromatography over SSCP for mutation detection in TSC2. Ann. Hum. Genet. 63, 383–391.
Narayanaswami, G. and Taylor, P. D. (2001) Improved efficiency of mutation detection by denaturing high-performance liquid chromatography using modified primers and hybridisation procedure. Genet. Test. 5, 9–16.
Bunn, C. F., Lintott, C. J., Scott, R. S., and George, P. M. (2002) Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort. Hum.Mutat. 19,311.
Yamamoto, N., Nakayama, J., Yamakawa-Kobayashi, K., Hamaguchi, H., Miyazaki, R., and Arinami, T. (2002) Identification of 33 polymorphisms in the adipocyte-derived leucine aminopeptidase (ALAP) gene and possible association with hypertension. Hum. Mutat. 19, 251–257.
Ranade, K., Wu, K., Hwu, C., Ting, C., Pei, D., and Pesich, R. (2001) Genetic variation in the human urea transporter-2 is associated with variation in blood pressure. Hum. Mol. Genet. 19, 2157–2164.
Transgenomic, Inc. (2001) Separation of DNA on the WAVE system in WAVEMAKER™ Software Version 4.1 Manual, pp. 1-7–1-12.
Transgenomic, Inc., San Jose, CA. Bioinformatics. http://www.transgenomic.com.
CMGS best practice guidelines for use of the WAVE system in diagnostic service. http://www.cmgs.org/BPG/Guidelines/2002/DHPLC.htm.
Muhr, D., Wagner, T., and Oefner, P. J. (2002) Polymerase chain reaction fidelity and denaturing high-performance liquid chromatography. J. Chromatogr. 782, 105–110.
Kaler, S. G., Devaney, J. M., Pettit, E. L., Kirshman, R., and Marino, M. A. (2000) Novel method for molecular detection of the two common hereditary hemochromatosis mutations. Genet. Test. 4,125–129.
Schmitt, T. J., Robinson, M. L., and Doyle, J. Transgenomic, Inc., San Jose, CA. (2000) Single nucleotide polymorphism (SNP), insertion & deletion detection on the WAVE® nucleic acid fragment analysis system. http://www.transgenomic.com, application note 112.
Transgenomic, Inc., San Jose, CA. (2001) Operating the WAVE system. In WAVEMAKER Software Version 4.1 Manual, pp. 4-24–4-35
Transgenomic, Inc., San Jose, CA. Standard Operating Procedure: Maintenance on the WAVE 3500 Systems. Unpublished material.
Transgenomic, Inc., San Jose, CA. (2001) Guided tour of WAVEMAKER Software. In WAVEMAKER™ Software Version 4.1 Manual, pp. 3-22–3-30.
Transgenomic, Inc., San Jose, CA. Gradient prediction (unpublished material).
Matayas, G., De Paepe, A., Halliday, D., Boileau, C., Pals, G., and Steinmann, B. (2002) Evaluation and application of denaturing HPLC for mutation detection in Marfan syndrome: identification of 20 novel mutations and two novel polymorphisms in the FBN1 gene. Hum. Mutat. 19, 443–456.
Transgenomic, Inc., San Jose, CA. Bioconsumables. http://www.transgenomic.com.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Donohoe, E. (2005). Denaturing High-Performance Liquid Chromatography Using the WAVE DNA Fragment Analysis System. In: Fennell, J.P., Baker, A.H. (eds) Hypertension. Methods In Molecular Medicine™, vol 108. Humana Press. https://doi.org/10.1385/1-59259-850-1:173
Download citation
DOI: https://doi.org/10.1385/1-59259-850-1:173
Publisher Name: Humana Press
Print ISBN: 978-1-58829-323-7
Online ISBN: 978-1-59259-850-2
eBook Packages: Springer Protocols